Novotech Featured Reports

  1. Gallbladder Cancer: Global Clinical Trial Landscape 9/11/2023

    Uncover how pipeline drugs, especially small molecules, offer the potential to transform gallbladder cancer management, ultimately improving patient outcomes and addressing its global impact.

  2. The Cell & Gene Therapy Clinical Trials Global Landscape 5/9/2023

    Gain valuable insights into the current state of cell and gene therapy clinical trials and the opportunities and challenges in this rapidly evolving field.

  3. What Are The Benefits Of A Well-Designed, Robust Preclinical Development Plan? 5/9/2023

    Discover how a well-designed and robust preclinical development plan can help identify potential safety and efficacy issues early in the drug development process, ultimately reducing the risk of failure in clinical trials.

  4. Acute Myeloid Leukemia: Global Clinical Trial Landscape - Focus On Asia Pacific 5/9/2023

    Gain a better understanding of the incidence, distribution, and possible control of acute myeloid leukemia (AML) in the Asia Pacific region, the standard of care, the trial landscape, and more.

  5. Prostate Cancer: Global Clinical Trial Landscape - Focus On Asia Pacific 5/9/2023

    Better understand the incidence, distribution, and possible control of prostate cancer (PCa) in the Asia Pacific region, the standard of care, the trial landscape, and more.

  6. Breast Cancer: Global Clinical Trial Landscape - Focus On Asia Pacific 5/9/2023

    Better understand the incidence, distribution, and possible control of breast cancer in the Asia Pacific region, the standard of care, the trial landscape, and more.

  7. Melanoma: Global Clinical Trial Landscape - Focus On Asia Pacific 5/9/2023

    Better understand the incidence, distribution, and possible control of melanoma in the Asia Pacific region, the standard of care, the trial landscape, and more.

  8. Ovarian Cancer: Global Clinical Trial Landscape - Focus On Asia Pacific 5/8/2023

    Better understand the incidence, distribution, and possible control of ovarian cancer (OC) in the Asia Pacific region, the standard of care, the trial landscape, and more.

  9. Designing A Global Drug Development Program To Secure FDA Approval 2/7/2023

    Global clinical trials in the Asia-Pacific region are becoming an attractive solution for young biotech companies looking to utilize their capital efficiently and secure high-quality clinical data quickly.

  10. Leveraging Global Drug Development Programs To Ensure Trial Success 2/7/2023

    Opting to take your biotech program global can help save crucial resources, produce high-quality clinical data for your therapy, and leverage unique regional advantages like region-specific indication strategies.